HSD17B13 and metabolic dysfunction-associated steatotic liver disease: The association of TM6SF2 rs58542926 C>T, HSD17B13 rs9992651 G>A, and GCKR rs1260326 T>C polymorphisms with NAFLD may be modified by the change in the population [7,14,25,26].